174
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Association Between Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome with Gallstone Disease, South Iran: A Population-Based Study

, ORCID Icon, ORCID Icon, & ORCID Icon
Pages 1449-1458 | Published online: 01 May 2020

References

  • Marschall HU, Einarsson C. Gallstone disease. J Intern Med. 2007;261(6):529–542. doi:10.1111/j.1365-2796.2007.01783.x
  • Reshetnyak VI. Concept of the pathogenesis and treatment of cholelithiasis. World J Hepatol. 2012;4(2):18–34. doi:10.4254/wjh.v4.i2.18
  • Miquel JF, Covarrubias C, Villaroel L, et al. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 1998;115(4):937–946. doi:10.1016/S0016-5085(98)70266-5
  • Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010;39(2):157–169. doi:10.1016/j.gtc.2010.02.003
  • Zamani F, Sohrabi MR, Motamed N, et al. Prevalence and risk factors of cholelithiasis in Amol city, Northern Iran: a population based study. Arch Iran Med. 2014;17(11):750–754.
  • Toosi FS, Ehsanbakhsh AR, Tavakoli MR. Asymptomatic gallstones and related risk factors in Iran. Hepatogastroenterology. 2010;58(109):1123–1126.
  • Massarrat S. Prevalence of gallstone disease in Iran. J Gastroenterol Hepatol. 2001;16(5):564–567. doi:10.1046/j.1440-1746.2001.02478.x
  • Méndez-Sánchez N, Chavez-Tapia NC, Motola-Kuba D, et al. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol. 2005;11(11):1653–1657. doi:10.3748/wjg.v11.i11.1653
  • Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595–1607. doi:10.2337/diab.37.12.1595
  • Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 2011;12(2):125–130. doi:10.1111/j.1751-2980.2011.00487.x
  • Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–923. doi:10.1053/jhep.2003.50161
  • Bray GA, Bellanger T. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. Endocrine. 2006;29(1):109–117. doi:10.1385/ENDO:29:1:109
  • Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28(4):339–350. doi:10.1055/s-0028-1091978
  • Milic S, Stimac D. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Dig Dis. 2012;30(2):158–162. doi:10.1159/000336669
  • Koch LK, Yeh MM. Nonalcoholic fatty liver disease (NAFLD): diagnosis, pitfalls, and staging. Ann Diagn Pathol. 2018;37:83–90. doi:10.1016/j.anndiagpath.2018.09.009
  • Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–81 e4. doi:10.1053/j.gastro.2018.12.036
  • Jaruvongvanich V, Sanguankeo A, Upala S. Significant association between gallstone disease and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Dig Dis Sci. 2016;61(8):2389–2396. doi:10.1007/s10620-016-4125-2
  • Shen SS, Gong JJ, Wang XW, et al. Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: a systematic review and meta-analysis. Turk J Gastroenterol. 2017;28(1):31–39. doi:10.5152/tjg.2016.0357
  • Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005;112(17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404
  • Stone NJ, Bilek S, Rosenbaum S. Recent national cholesterol education program adult treatment panel III update: adjustments and options. Am J Cardiol. 2005;96(4):53E–9E. doi:10.1016/j.amjcard.2005.06.006
  • Azizi F, Hadaegh F, Khalili D, et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med. 2010;13(5):426–428.
  • Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123(3):745–750. doi:10.1053/gast.2002.35354
  • Kim SS, Lee JG, Kim DW, et al. Insulin resistance as a risk factor for gallbladder stone formation in Korean postmenopausal women. Korean J Intern Med. 2011;26(3):285–293. doi:10.3904/kjim.2011.26.3.285
  • Tung TH, Ho HM, Shin HC, et al. A population-based follow-up study on gallstone disease among type 2 diabetics in Kinmen, Taiwan. World J Gastroenterol. 2006;12(28):4536–4540. doi:10.3748/wjg.v12.i28.4536
  • Grundy SM. Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr. 2004;80(1):1–2. doi:10.1093/ajcn/80.1.1
  • Kern Jr F, Erfling W, Braverman D. Why more women than men have cholesterol gallstones: studies of biliary lipids in pregnancy. Trans Am Clin Climatol Assoc. 1979;90:71–75.
  • Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7(2):132–140. doi:10.1007/s11894-005-0051-8
  • Chang Y, Sung E, Ryu S, Park YW, Jang YM, Park M. Insulin resistance is associated with gallstones even in non-obese, non-diabetic Korean men. J Korean Med Sci. 2008;23(4):644–650. doi:10.3346/jkms.2008.23.4.644
  • Ata N, Kucukazman M, Yavuz B, et al. The metabolic syndrome is associated with complicated gallstone disease. Can J Gastroenterol. 2011;25(5):274–276. doi:10.1155/2011/356761
  • Pitt HA. Hepato-pancreato-biliary fat: the good, the bad and the ugly. HPB. 2007;9(2):92–97. doi:10.1080/13651820701286177
  • Ilychenko AA. Gallstone disease. Lechashchiy Vrach. 2004;4:27–33.
  • Chen LY, Qiao QH, Zhang SC, Chen YH, Chao GQ, Fang LZ. Metabolic syndrome and gallstone disease. World J Gastroenterol. 2012;18(31):4215–4220. doi:10.3748/wjg.v18.i31.4215
  • Lonardo A, Lombardini S, Scaglioni F, et al. Fatty liver, carotid disease and gallstones: a study of age-related associations. World J Gastroenterol. 2006;12(36):5826–5833. doi:10.3748/wjg.v12.i36.5826
  • Fracanzani AL, Valenti L, Russello M, et al. Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. PLoS One. 2012;7(7):e41183. doi:10.1371/journal.pone.0041183
  • Koller T, Kollerova J, Hlavaty T, Huorka M, Payer J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand J Gastroenterol. 2012;47(2):197–203. doi:10.3109/00365521.2011.643481
  • Liu J, Lin H, Zhang C, et al. Non-alcoholic fatty liver disease associated with gallstones in females rather than males: a longitudinal cohort study in Chinese urban population. BMC Gastroenterol. 2014;14(1):213. doi:10.1186/s12876-014-0213-y
  • Qiao QH, Zhu WH, Yu YX, Huang FF, Chen LY. Nonalcoholic fatty liver was associated with asymptomatic gallstones in a Chinese population. Medicine (Baltimore). 2017;96(38):e7853. doi:10.1097/MD.0000000000007853
  • Ahmed F, Baloch Q, Memon ZA, Ali I. An observational study on the association of nonalcoholic fatty liver disease and metabolic syndrome with gall stone disease requiring cholecystectomy. Ann Med Surg. 2017;17:7–13. doi:10.1016/j.amsu.2017.03.015
  • Garcia-Monzon C, Vargas-Castrillon J, Porrero JL, et al. Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones. Liver Int. 2015;35(8):1983–1991. doi:10.1111/liv.12813
  • Yilmaz Y, Ayyildiz T, Akin H, et al. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. Gut Liver. 2014;8(3):313–317. doi:10.5009/gnl.2014.8.3.313
  • Kim YK, Kwon OS, Her KH. The grade of nonalcoholic fatty liver disease is an independent risk factor for gallstone disease: an observational study. Medicine (Baltimore). 2019;98(27):e16018. doi:10.1097/MD.0000000000016018
  • Chang Y, Noh YH, Suh BS, et al. Bidirectional association between nonalcoholic fatty liver disease and gallstone disease: a cohort study. J Clin Med. 2018;7(11):458. doi:10.3390/jcm7110458
  • Lee YC, Wu JS, Yang YC, Chang CS, Lu FH, Chang CJ. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scand J Gastroenterol. 2014;49(8):1001–1006. doi:10.3109/00365521.2014.920912
  • Yue W, Sun X, Du T. Cholecystectomy versus central obesity or insulin resistance in relation to the risk of nonalcoholic fatty liver disease: the third US National Health and Nutrition Examination Survey. BMC Endocr Disord. 2019;19(1):95. doi:10.1186/s12902-019-0423-y
  • Kwak MS, Kim D, Chung GE, Kim W, Kim YJ, Yoon JH. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. World J Gastroenterol. 2015;21(20):6287–6295. doi:10.3748/wjg.v21.i20.6287
  • Ruhl CE, Everhart JE. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol. 2013;108(6):952–958. doi:10.1038/ajg.2013.70
  • Yener O, Aksoy F, Demir M, Ozcelik A, Erengul C. Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome. Turk J Gastroenterol. 2010;21(4):411–415. doi:10.4318/tjg.2010.0128
  • Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol. 2014;20(44):16649–16664. doi:10.3748/wjg.v20.i44.16649
  • Montet JC, Caroli-Bosc FX, Ferrari P, et al. Gallbladder motility and gut hormone plasma levels in subjects with and without gallstones. Gastroenterol Clin Biol. 2005;29(5):569–572. doi:10.1016/S0399-8320(05)82131-1
  • Ballestri S, Nascimbeni F, Lugari S, Lonardo A, Francica G. A critical appraisal of the use of ultrasound in hepatic steatosis. Expert Rev Gastroenterol Hepatol. 2019;13(7):667–681. doi:10.1080/17474124.2019.1621164